AI assistant
Sending…
Apellis Pharmaceuticals, Inc. — Director's Dealing 2021
Sep 1, 2021
31417_dirs_2021-09-01_b80ee4ef-ad2f-42dc-b7a5-2ba4d88859be.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Apellis Pharmaceuticals, Inc. (APLS)
CIK: 0001492422
Period of Report: 2021-08-30
Reporting Person: Chopas James George (See Remarks)
More from Apellis Pharmaceuticals, Inc.
Regulatory Filings
2026
May 14
Regulatory Filings
2026
May 14
Regulatory Filings
2026
May 14
Regulatory Filings
2026
May 14
Regulatory Filings
2026
May 14
Regulatory Filings
2026
May 14
Share Issue/Capital Change
2026
May 14
Regulatory Filings
2026
May 14
Regulatory Filings
2026
May 14
Regulatory Filings
2026
May 14